Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Neben, Kai; Lokhorst, Henk M.; Jauch, Anna; Bertsch, Uta; Hielscher, Thomas; van der Holt, Bronno; Salwender, Hans; Blau, Igor W.; Weisel, Katja; Pfreundschuh, Michael; Scheid, Christof; Duehrsen, Ulrich; Lindemann, Walter; Schmidt-Wolf, Ingo G. H.; Peter, Norma; Teschendorf, Christian; Martin, Hans; Haenel, Mathias; Derigs, Hans G.; Raab, Marc S.; Ho, Anthony D.; van de Velde, Helgi; Hose, Dirk; Sonneveld, Pieter; Goldschmidt, Hartmut

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Autor(en):

Neben, Kai; Lokhorst, Henk M.; Jauch, Anna; Bertsch, Uta; Hielscher, Thomas; van der Holt, Bronno; Salwender, Hans; Blau, Igor W.; Weisel, Katja; Pfreundschuh, Michael; Scheid, Christof; Duehrsen, Ulrich; Lindemann, Walter; Schmidt-Wolf, Ingo G. H.; Peter, Norma; Teschendorf, Christian; Martin, Hans; Haenel, Mathias; Derigs, Hans G.; Raab, Marc S.; Ho, Anthony D.; van de Velde, Helgi; Hose, Dirk; Sonneveld, Pieter; Goldschmidt, Hartmut

Tübinger Autor(en):

Weisel, Katja

Erschienen in:

Blood (2012), Bd. 119, H. 4, S. 940-948

Verlagsangabe:

Amer Soc Hematology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1182/blood-2011-09-379164

ISSN:

0006-4971